How to Cite
Medina, O. L., Luna, R. D., Pardo, K., & Dávila, F. A. (2017). Intensidad y frecuencia de alteraciones del metabolismo óseo postrasplante renal. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 3(4), 6–10. https://doi.org/10.53853/encr.3.4.3
Abstract
Los pacientes llevados a trasplante renal, potencialmente desarrollan enfermedad ósea relacionada con trasplante, esta ocurre tempranamente luego del trasplante, con una rápida disminución en la densidad mineral ósea en los primeros 6 a 12 meses, de origen multifactorial; combina alteraciones en el metabolismo del calcio, fósforo, hormona paratiroidea (PTH) y vitamina D después de trasplante renal exitoso.
References
1. Nishioka S, Sofue T, Inui M, et al. Mineral and bone disorder is temporary in patients treated with early rapid corticosteroid reduction after kidney transplantation: a single-center experience. Transplant Proc. 2014;46(2):514-520. doi:10.1016/j.transproceed.2013.11.153.
2. Perrin P, Caillard S, Javier RM, et al. Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation. Am J Transplant. 2013;13(10):2653-2663. doi:10.1111/ajt.12425.
3. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;2(113):S1-S130. doi:10.1038/ ki.2009.188.
4. Kwon YE, Kim H, Oh HJ, et al. Vitamin D Deficiency Is an Independent Risk Factor for Urinary Tract Infections After Renal Transplants. Medicine (Baltimore). 2015;94(9):e594. doi:10.1097/MD.0000000000000594.
5. Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP. Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation. 2009;87(7):1040-1044. doi:10.1097/TP.0b013e31819cd122.
6. Evenepoel P, Meijers BKI, de Jonge H, et al. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol. 2008;3(6):1829-1836. doi:10.2215/ CJN.01310308.
7. Lou I, Foley D, Odorico SK, et al. How Well Does Renal Transplantation Cure Hyperparathyroidism? Ann Surg. 2015;262(4):653-659. doi:10.1097/ SLA.0000000000001431.
8. Khalili N, Rostami Z, Kalantar E, Einollahi B. Hyperglycemia after renal transplantation: Frequency and risk factors. Nephrourol Mon. 2013;5(2):753- 757. doi:10.5812/numonthly.10773.
9. Central H, Privado H, Cannata JB. Trastornos del metabolismo óseo y mineral en el trasplante renal. 2015;14(33080):1-9.
10. Einollahi B, Taheri S. Renal transplantation practice in Iran and the middle east: report from Iran and a review of the literature. Ann Transpl. 2008;13(1):5-14.
11. Hesketh CC, Knoll GA, Molnar AO, Tsampalieros A, Zimmerman DL. Vitamin D and kidney transplant outcomes: a protocol for a systematic review and metaanalysis. Syst Rev. 2014;3(1):64. doi:10.1186/2046-4053-3-64.
12. National Kidney Foundation. Parathyroid Hormone and Secondary Hyperparathyroidism in Chronic Kidney Disease.; 2012. https://www.kidney.org/ sites/default/files/02-10-4899_GB_SHPT-PTH_v8.pdf.
13. Ostovan MA, Fazelzadeh A, Mehdizadeh AR, Razmkon A, Malek-Hosseini S-A. How to decrease cardiovascular mortality in renal transplant recipients. Transplant Proc. 2006;38(9):2887-2892. doi:10.1016/j.transproceed.2006.08.091.
14. Cianciolo G, Capelli I, Angelini ML, et al. Importance of vascular calcification in kidney transplant recipients. Am J Nephrol. 2014;39(5):418-426. doi:10.1159/000362492.
15. Kurowski A. Comparative Analysis of Hypertension and its Causes among Renal Replacement Therapy Patients. Ann Transplant. 2014;19:556-568. doi:10.12659/AOT.891248.
16. Vipattawat K, Kitiyakara C, Phakdeekitcharoen B, et al. Vascular calcification in long-term kidney transplantation. Nephrology (Carlton). 2014;19(4):251-256. doi:10.1111/nep.12210.
2. Perrin P, Caillard S, Javier RM, et al. Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation. Am J Transplant. 2013;13(10):2653-2663. doi:10.1111/ajt.12425.
3. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;2(113):S1-S130. doi:10.1038/ ki.2009.188.
4. Kwon YE, Kim H, Oh HJ, et al. Vitamin D Deficiency Is an Independent Risk Factor for Urinary Tract Infections After Renal Transplants. Medicine (Baltimore). 2015;94(9):e594. doi:10.1097/MD.0000000000000594.
5. Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP. Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation. 2009;87(7):1040-1044. doi:10.1097/TP.0b013e31819cd122.
6. Evenepoel P, Meijers BKI, de Jonge H, et al. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol. 2008;3(6):1829-1836. doi:10.2215/ CJN.01310308.
7. Lou I, Foley D, Odorico SK, et al. How Well Does Renal Transplantation Cure Hyperparathyroidism? Ann Surg. 2015;262(4):653-659. doi:10.1097/ SLA.0000000000001431.
8. Khalili N, Rostami Z, Kalantar E, Einollahi B. Hyperglycemia after renal transplantation: Frequency and risk factors. Nephrourol Mon. 2013;5(2):753- 757. doi:10.5812/numonthly.10773.
9. Central H, Privado H, Cannata JB. Trastornos del metabolismo óseo y mineral en el trasplante renal. 2015;14(33080):1-9.
10. Einollahi B, Taheri S. Renal transplantation practice in Iran and the middle east: report from Iran and a review of the literature. Ann Transpl. 2008;13(1):5-14.
11. Hesketh CC, Knoll GA, Molnar AO, Tsampalieros A, Zimmerman DL. Vitamin D and kidney transplant outcomes: a protocol for a systematic review and metaanalysis. Syst Rev. 2014;3(1):64. doi:10.1186/2046-4053-3-64.
12. National Kidney Foundation. Parathyroid Hormone and Secondary Hyperparathyroidism in Chronic Kidney Disease.; 2012. https://www.kidney.org/ sites/default/files/02-10-4899_GB_SHPT-PTH_v8.pdf.
13. Ostovan MA, Fazelzadeh A, Mehdizadeh AR, Razmkon A, Malek-Hosseini S-A. How to decrease cardiovascular mortality in renal transplant recipients. Transplant Proc. 2006;38(9):2887-2892. doi:10.1016/j.transproceed.2006.08.091.
14. Cianciolo G, Capelli I, Angelini ML, et al. Importance of vascular calcification in kidney transplant recipients. Am J Nephrol. 2014;39(5):418-426. doi:10.1159/000362492.
15. Kurowski A. Comparative Analysis of Hypertension and its Causes among Renal Replacement Therapy Patients. Ann Transplant. 2014;19:556-568. doi:10.12659/AOT.891248.
16. Vipattawat K, Kitiyakara C, Phakdeekitcharoen B, et al. Vascular calcification in long-term kidney transplantation. Nephrology (Carlton). 2014;19(4):251-256. doi:10.1111/nep.12210.
Authors must state that they reviewed, validated and approved the manuscript's publication. Moreover, they must sign a model release that should be sent. A copy may be reviewed here